Staphylococcus aureus virulence is enhanced by secreted factors that block innate immune defenses.

Journal of Innate Immunity
Ilse JongeriusSuzan H M Rooijakkers

Abstract

Staphylococcus aureus is a leading human pathogen that causes a large variety of diseases. In vitro studies have shown that S. aureus secretes several small proteins that block specific elements of the host innate immune system, but their role in bacterial pathogenicity is unknown. For instance, the extracellular complement-binding protein (Ecb) impairs complement activation by binding to the C3d domain of C3. Its homolog, the extracellular fibrinogen-binding protein (Efb), is known to block both complement activation and neutrophil adhesion to fibrinogen. Here, we show that targeted inactivation of the genes encoding Ecb and Efb strongly attenuates S. aureus virulence in a murine infection model: mice experienced significantly higher mortality rates upon intravenous infection with wild-type bacteria (79%) than with an isogenic ΔEcbΔEfb mutant (21%). In addition, Ecb and Efb are both required for staphylococcal persistence in host tissues and abscess formation in the kidneys (27% for wild-type vs. 7% for the ΔEcbΔEfb mutant). During staphylococcal pneumonia, Ecb and Efb together promote bacterial survival in the lungs (p = 0.03) and block neutrophil influx into the lungs. Thus, Ecb and Efb are essential to S. aureus virulence i...Continue Reading

References

Jan 1, 1994·Annual Review of Microbiology·J M PattiM Höök
May 23, 2001·The Journal of Experimental Medicine·C B ForsythE F Plow
Jun 5, 2001·Blood·A F DrewJ L Degen
Mar 14, 2003·Microbiology·Steve GrkovicRonald A Skurray
Nov 22, 2005·Infection and Immunity·Kazue TakahashiR Alan B Ezekowitz
Feb 25, 2006·Nature Reviews. Immunology·Carl Nathan
Sep 19, 2006·The Journal of Pathology·D Cruz-TopeteF J Castellino
Sep 22, 2006·Blood Reviews·Alexander ZarbockKlaus Ley
Nov 15, 2006·Infection and Immunity·Juliane Bubeck WardenburgOlaf Schneewind
Feb 8, 2007·Emerging Infectious Diseases·Linda F McCaigDaniel B Jernigan
Aug 8, 2007·Trends in Immunology·Triantafyllos ChavakisMathias Herrmann
Aug 19, 2007·The Journal of Biological Chemistry·Michal HammelBrian V Geisbrecht
Sep 26, 2007·The Journal of Experimental Medicine·Ilse JongeriusSuzan H M Rooijakkers
Oct 18, 2007·JAMA : the Journal of the American Medical Association·R Monina KlevensUNKNOWN Active Bacterial Core surveillance (ABCs) MRSA Investigators
Jul 16, 2008·The Journal of Surgical Research·Charles M RobertsonCraig M Coopersmith
Sep 2, 2008·International Journal of Antimicrobial Agents·Adam C Schaffer, Jean C Lee
Apr 22, 2009·PloS One·J Merlijn van den BergTaco W Kuijpers
Jun 16, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Alice G ChengDominique M Missiakas
Sep 17, 2009·Journal of Innate Immunity·Jan Potempa, Robert N Pike
Oct 17, 2009·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·N J VerkaikW J B van Wamel
Apr 9, 2010·Journal of Innate Immunity·Maren von Köckritz-BlickwedeEva Medina
May 15, 2010·Nature Reviews. Microbiology·Davide SerrutoJos A G van Strijp
Aug 18, 2010·The Journal of Experimental Medicine·Hwan Keun KimOlaf Schneewind
Aug 20, 2010·Nature Immunology·Daniel RicklinJohn D Lambris
Jan 21, 2011·The Journal of Biological Chemistry·Ya-Ping KoMagnus Höök
Apr 20, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Alexander J LaarmanSuzan H M Rooijakkers

❮ Previous
Next ❯

Citations

Jul 10, 2013·Annual Review of Microbiology·András N SpaanJos A G van Strijp
Aug 2, 2012·The EMBO Journal·Alexander J LaarmanSuzan H M Rooijakkers
Aug 15, 2015·Nature Reviews. Microbiology·Vilasack ThammavongsaOlaf Schneewind
Apr 23, 2016·Journal of Nanobiotechnology·Yan XuTatsiana Mironava
Jun 19, 2012·Free Radical Biology & Medicine·Jeong-Chae LeeXianglin Shi
Oct 4, 2015·Redox Biology·Joe Dan DunnThierry Soldati
Oct 11, 2016·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·S HraiechL Papazian
Nov 22, 2013·Journal of Personality Disorders·Mark ZimmermanKristy Dalrymple
Dec 9, 2015·The Australian and New Zealand Journal of Psychiatry·Gin S MalhiAjeet B Singh
Sep 6, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Maria Georgoutsou-SpyridonosGeorgia Sfyroera
Nov 20, 2015·Physiological Reviews·Dane ParkerAlice Prince
Jul 19, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hanne AmdahlT Sakari Jokiranta
Jan 10, 2017·Frontiers in Microbiology·Elise S HovinghIlse Jongerius
Dec 6, 2017·Cell and Tissue Research·Megan L Lewis, Bas G J Surewaard
Nov 30, 2019·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Juliane HandschuhAndreas J Müller
Feb 2, 2021·Virulence·Gordon Y C CheungMichael Otto
Mar 31, 2019·Microbiology Spectrum·Nienke W M de JongJos A G van Strijp
May 21, 2021·MSphere·Mariane PivardFrançois Vandenesch
Jul 1, 2021·Open Forum Infectious Diseases·Franziska SchulerFrieder Schaumburg
Dec 1, 2021·Journal of Thrombosis and Haemostasis : JTH·Stuart WallisGiordano Pula

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Bacterial Protein Structures

Bacterial protein structures can expedite the development of novel antibiotics. Here is the latest research on bacterial proteins and the resolution of their structures.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Related Papers

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
A ChengDominique Missiakas
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases
Alex J McCarthy, Jodi A Lindsay
© 2022 Meta ULC. All rights reserved